Christian is a seasoned Market Access professional with over 20 years of experience in the International Biotech and Pharmaceutical industry. He has been involved in over 50 HTAs across Europe and has built up a strong network of key influencers including EU and national agencies. Prior to co-founding MAP in 2012, he led market access teams and submissions at InterMune, Gilead, Pfizer and Genzyme on a very broad range of products and disease areas from chronic disease to ultra-orphan indications.

Christian is a member of the Board of EUCOPE (European Confederation of Pharmaceutical Entrepreneurs); he is also a member of the Steering Group of EMIG (Ethical Medicines Industry Group) in the UK and Ireland.

Angelika began her legal journey in Poland where she obtained a Master's Degree in Law and gained experience in international corporate and commercial law. Having developed an interest in the common law system, Angelika has recently graduated from BPP University with a Distinction in Graduate Diploma in Law. She actively supports MAP clients and members by conducting legal research, as well as leading the development of MAP Online Legal section with insights in the areas of marketing authorisation, intellectual property, data protection, Brexit and EU competition law. She also has expertise in the ABPI Code of Practice and regularly participates in conferences and meeting groups where she helps realise MAP’s vision to accelerate patient access to medicines, medical devices and diagnostics.

Tessa has over 10 years’ experience in policy and public affairs. She has worked for charities and spent seven years within two award-winning healthcare communications consultancies working across a range of areas, including corporate communications, cancer, cardiovascular disease and diabetes. She has a detailed understanding of the UK health policy environment, including access to medicines issues, levers and incentives and new care models. She has managed a range of successful campaigns, including securing better access to medicines and support for improved cancer awareness.

Alexander Natz is the Secretary General of the European Confederation of Pharmaceutical Entrepreneurs (www.eucope.org) in Brussels and works as a lawyer in the healthcare boutique law firm NOVACOS in Düsseldorf (www.novacos-law.com). He advises innovative pharmaceutical and biotech companies, including start-ups, in regulatory and pricing & reimbursement matters from the EU law and German law perspective.

From 2008 to 2013, he was Head of the Brussels Office of Bundesverband der Pharmazeutischen Industrie eV (BPI). Before, he has been a lawyer at Sträter Law Firm in Germany with a special focus on managed entry agreements and licensing of pharmaceuticals. Dr. Natz has also worked in the field of competition law with the European Commission and in the pharmaceutical industry.